{"transactions":[{"id":1110376,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-16T20:05:14.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is immediately exercisable in full, but any unvested shares that are purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's Continuous Service (as defined in the 2018 EIP). The shares subject to the option will vest in 12 successive equal monthly installments following the grant date, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":50000,"derivative":{"exercise_price":0.503,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-017369","document":"form4-06162025_040605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588925017369/form4-06162025_040605.xml","form_type":"4"}},{"id":1110375,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T20:05:14.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of a restricted stock unit (\"RSU\") grant that will fully vest on the earlier of (a) June 12, 2026 or (b) the day prior to the 2026 annual meeting of stockholders, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\")) through such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":99600,"source":{"system":"sec-edgar","filing":"0001415889-25-017369","document":"form4-06162025_040605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588925017369/form4-06162025_040605.xml","form_type":"4"}},{"id":1488909,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T20:23:57.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is immediately exercisable in full, but any unvested shares that are purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's Continuous Service (as defined in the 2018 EIP). The shares subject to the option will vest in 12 successive equal monthly installments following the grant date, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":50000,"derivative":{"exercise_price":0.5676,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-24-015754","document":"form4-06062024_080652.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588924015754/form4-06062024_080652.xml","form_type":"4"}},{"id":1488908,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T20:23:57.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of a restricted stock unit (\"RSU\") grant that will fully vest on the earlier of (a) June 4, 2025 or (b) the day prior to the 2025 annual meeting of stockholders, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\")) through such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":74600,"source":{"system":"sec-edgar","filing":"0001415889-24-015754","document":"form4-06062024_080652.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000141588924015754/form4-06062024_080652.xml","form_type":"4"}},{"id":1717848,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-08T17:17:20.000Z","date":"2023-12-07","kind":"grant","planned":false,"acquired":true,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on date of next annual general meeting following grant date of December 7, 2023."}],"balance_after":37000,"derivative":{"exercise_price":9.55,"expiration_date":"2033-12-06","underlying":"Common Stock","underlying_shares":37000},"source":{"system":"sec-edgar","filing":"0000950170-23-069104","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600359/000095017023069104/ownership.xml","form_type":"4"}},{"id":1864591,"issuer":{"id":76268,"kind":"organization","name":"Chrome Holding Co.","symbol":"MEHCQ"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Therapeutics Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-07T16:20:51.000Z","date":"2023-06-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":15347,"price":2.08,"value":31921.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The closing price on June 5, 2023, the fair market value used for the transaction date."}],"balance_after":221876,"source":{"system":"sec-edgar","filing":"0001209191-23-035076","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804591/000120919123035076/doc4.xml","form_type":"4"}},{"id":1864590,"issuer":{"id":76268,"kind":"organization","name":"Chrome Holding Co.","symbol":"MEHCQ"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Therapeutics Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-07T16:20:51.000Z","date":"2023-06-05","kind":"grant","planned":false,"acquired":true,"shares":44381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units (the \"RSUs\") granted under the 23andMe Amended and Restated Annual Incentive Plan and the 23andMe Holding Co. 2021 Incentive Equity Plan (together, the \"Plans\") as payment of the reporting person's annual incentive bonus for the fiscal year ended March 31, 2023. The RSUs are fully vested at the time of grant and are subject to the terms and conditions of the Plans, the applicable award agreement, and applicable tax withholding obligations. Each RSU represents the contingent right to receive one share of Class A common stock of 23andMe Holding Co."}],"balance_after":237223,"source":{"system":"sec-edgar","filing":"0001209191-23-035076","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804591/000120919123035076/doc4.xml","form_type":"4"}},{"id":1868071,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-05T20:48:02.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":27750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is immediately exercisable in full, but any unvested shares that are purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's Continuous Service (as defined in the 2018 EIP). The shares subject to the option will vest in 12 successive equal monthly installments following the grant date, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":27750,"derivative":{"exercise_price":1.11,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":27750},"source":{"system":"sec-edgar","filing":"0001209191-23-034390","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919123034390/doc4.xml","form_type":"4"}},{"id":1868070,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T20:48:02.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":13900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of a restricted stock unit (\"RSU\") grant that will fully vest on the earlier of (a) June 1, 2024 or (b) the day prior to the 2024 annual meeting of stockholders, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\")) through such date and subject to acceleration as provided in the 2018 EIP."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,000 shares subject to the Reporting Person's September 9, 2020 RSU grant that will vest in one final installment on September 9, 2023."}],"balance_after":49600,"source":{"system":"sec-edgar","filing":"0001209191-23-034390","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919123034390/doc4.xml","form_type":"4"}},{"id":1881727,"issuer":{"id":76268,"kind":"organization","name":"Chrome Holding Co.","symbol":"MEHCQ"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Therapeutics Officer"}}],"security":"Class A Common Stock","published_at":"2023-05-23T16:05:47.000Z","date":"2023-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":4628,"price":1.94,"value":8978.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The closing price on May 19, 2023, the fair market value used for the transaction date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,765 shares acquired under the 23andMe Holding Co. 2021 Employee Stock Purchase Plan on February 28, 2023."}],"balance_after":192842,"source":{"system":"sec-edgar","filing":"0001209191-23-031655","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804591/000120919123031655/doc4.xml","form_type":"4"}},{"id":2002001,"issuer":{"id":76268,"kind":"organization","name":"Chrome Holding Co.","symbol":"MEHCQ"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Therapeutics Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-22T17:12:54.000Z","date":"2023-02-20","kind":"tax_withholding","acquired":false,"shares":5457,"price":2.87,"value":15661.59,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The closing price on February 17, 2023, the fair market used for the transaction date."}],"balance_after":191705,"source":{"system":"sec-edgar","filing":"0001209191-23-011754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804591/000120919123011754/doc4.xml","form_type":"4"}},{"id":2076737,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-23T19:00:14.000Z","date":"2022-12-21","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on date of next annual general meeting following grant date of December 21, 2022."}],"balance_after":25000,"derivative":{"exercise_price":8.75,"expiration_date":"2032-12-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-22-039322","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600359/000089924322039322/doc4.xml","form_type":"4"}},{"id":2107772,"issuer":{"id":76268,"kind":"organization","name":"Chrome Holding Co.","symbol":"MEHCQ"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Therapeutics Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-22T16:11:31.000Z","date":"2022-11-20","kind":"tax_withholding","acquired":false,"shares":4628,"price":2.99,"value":13837.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The closing price on November 18, 2022, the fair market used for the transaction date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,707 shares acquired under the 23andMe Holding Co. 2021 Employee Stock Purchase Plan on August 31, 2022."}],"balance_after":197162,"source":{"system":"sec-edgar","filing":"0001209191-22-058361","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804591/000120919122058361/doc4.xml","form_type":"4"}},{"id":2174403,"issuer":{"id":76268,"kind":"organization","name":"Chrome Holding Co.","symbol":"MEHCQ"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Therapeutics Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-25T17:00:03.000Z","date":"2022-08-24","kind":"sale","acquired":false,"shares":8753,"price":3.64,"value":31860.92,"ownership":{"direct":true},"balance_after":196083,"source":{"system":"sec-edgar","filing":"0001209191-22-047540","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804591/000120919122047540/doc4.xml","form_type":"4"}},{"id":2177476,"issuer":{"id":76268,"kind":"organization","name":"Chrome Holding Co.","symbol":"MEHCQ"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Therapeutics Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-22T18:12:08.000Z","date":"2022-08-20","kind":"tax_withholding","acquired":false,"shares":4628,"price":3.33,"value":15411.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The closing price on August 19, 2022, the fair market used for the transaction date."}],"balance_after":204836,"source":{"system":"sec-edgar","filing":"0001209191-22-047067","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804591/000120919122047067/doc4.xml","form_type":"4"}},{"id":2248483,"issuer":{"id":76268,"kind":"organization","name":"Chrome Holding Co.","symbol":"MEHCQ"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Therapeutics Officer"}}],"security":"Class A Common Stock","published_at":"2022-06-02T16:26:02.000Z","date":"2022-06-01","kind":"tax_withholding","acquired":false,"shares":4627,"price":2.82,"value":13048.14,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The closing price on June 1, 2022, the transaction date."}],"balance_after":209464,"source":{"system":"sec-edgar","filing":"0001209191-22-033526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804591/000120919122033526/doc4.xml","form_type":"4"}},{"id":2366620,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-01T22:09:01.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is immediately exercisable in full, but any unvested shares that are purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's Continuous Service (as defined in the 2018 EIP). The shares subject to the option will vest in 12 successive equal monthly installments following the grant date, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":25000,"derivative":{"exercise_price":5.9,"expiration_date":"2032-02-24","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-014134","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919122014134/doc4.xml","form_type":"4"}},{"id":2366619,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-01T22:09:01.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of a restricted stock unit (\"RSU\") grant that will fully vest on the first anniversary of the grant date, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP\")) through such date and subject to acceleration as provided in the 2018 EIP."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 10,000 shares subject to the Reporting Person's September 9, 2020 RSU grant that will vest in two remaining annual installments of 5,000 shares on each of September 9, 2022 and 2023, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP."}],"balance_after":35700,"source":{"system":"sec-edgar","filing":"0001209191-22-014134","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919122014134/doc4.xml","form_type":"4"}},{"id":2402888,"issuer":{"id":76268,"kind":"organization","name":"Chrome Holding Co.","symbol":"MEHCQ"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Therapeutics"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-11T16:23:37.000Z","date":"2022-02-09","kind":"grant","acquired":true,"shares":471413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of stock options under the Plan.  The stock options vest equally in 1/48 monthly installments commencing on March 9, 2022.  The vesting of the options is subject to continued service for the Company, the terms and conditions of the applicable award agreement, and applicable tax withholding obligations."}],"balance_after":471413,"derivative":{"exercise_price":5,"expiration_date":"2032-02-09","underlying":"Class A Common Stock","underlying_shares":471413},"source":{"system":"sec-edgar","filing":"0001209191-22-008865","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804591/000120919122008865/doc4.xml","form_type":"4"}},{"id":2402887,"issuer":{"id":76268,"kind":"organization","name":"Chrome Holding Co.","symbol":"MEHCQ"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Therapeutics"}}],"security":"Class A Common Stock","published_at":"2022-02-11T16:23:37.000Z","date":"2022-02-09","kind":"grant","acquired":true,"shares":214091,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock units (the \"RSUs\") under the 23andMe Holding Co's (the \"Company\") 2021 Incentive Equity Plan (the \"Plan\"). The RSUs vest equally in 1/16 quarterly installments commencing on May 20, 2022. The vesting of the RSUs is subject to continued service for the Company, the terms and conditions of the applicable award agreement, and applicable tax withholding obligations. Each RSU represents the contingent right to receive one share of Class A common stock of the Company."}],"balance_after":214091,"source":{"system":"sec-edgar","filing":"0001209191-22-008865","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804591/000120919122008865/doc4.xml","form_type":"4"}},{"id":2723150,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-07T20:45:33.000Z","date":"2021-05-06","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on date of next annual general meeting following grant date of May 6, 2021."}],"balance_after":9000,"derivative":{"exercise_price":29.49,"expiration_date":"2031-05-05","underlying":"Common Shares","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000899243-21-018767","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600359/000089924321018767/doc4.xml","form_type":"4"}},{"id":2827635,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-02T01:57:56.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":16400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option is immediately exercisable for all option shares, but shares purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's Continuous Service (as defined in the 2018 EIP, as amended). The shares subject to the option vest in 12 successive equal monthly installments upon the Reporting Person's completion of each month of Continuous Service (as defined in the 2018 EIP, as amended) over the 12-month period measured from the grant date and subject to acceleration as provided in the 2018 EIP, as amended."}],"balance_after":16400,"derivative":{"exercise_price":11.19,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":16400},"source":{"system":"sec-edgar","filing":"0001209191-21-015499","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919121015499/doc4.xml","form_type":"4"}},{"id":2827634,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-02T01:57:56.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":8200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of restricted stock units (\"RSUs\"). The RSUs will fully vest on the first anniversary of the date of grant, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP, as amended\")), through such date and subject to acceleration as provided in the 2018 EIP, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,000 shares of common stock issuable upon settlement of RSUs subject to Reporting Person's September 9, 2020 RSU grant that vest with respect to 1/3rd of the shares in three equal annual installments over the three-year period measured from the date of grant, subject to the Reporting Person's Continuous Service as defined in the 2018 EIP, as amended, through such dates and subject to acceleration as defined in the 2018 EIP, as amended."}],"balance_after":23200,"source":{"system":"sec-edgar","filing":"0001209191-21-015499","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919121015499/doc4.xml","form_type":"4"}},{"id":3033609,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-11T22:18:53.000Z","date":"2020-09-09","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each option is immediately exercisable for all option shares, however shares purchased pursuant to the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's Continuous Service, as defined in the 2018 EIP, as amended. The shares subject to the option vest in 36 successive equal monthly installments upon completion of each month of Continuous Service, as defined in the 2018 EIP, as amended, by the Reporting Person measured from the September 9, 2020 grant date, through each such vesting date, and subject to acceleration as provided in the 2018 EIP, as amended."}],"balance_after":30000,"derivative":{"exercise_price":10.43,"expiration_date":"2030-09-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-20-050208","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919120050208/doc4.xml","form_type":"4"}},{"id":3033608,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-11T22:18:53.000Z","date":"2020-09-09","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 15,000 shares of common stock issuable upon settlement of restricted stock units (\"RSUs\") granted to the Reporting Person on September 9, 2020. The RSUs will vest with respect to 1/3rd of the shares in three equal annual installments over the three-year period measured from the date of grant, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP, as amended\")), through such dates and subject to acceleration as defined in the 2018 EIP, as amended."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001209191-20-050208","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919120050208/doc4.xml","form_type":"4"}},{"id":3152740,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-12T06:31:24.000Z","date":"2020-05-08","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on date of next annual general meeting following grant date of May 8, 2020."}],"balance_after":9000,"derivative":{"exercise_price":35.49,"expiration_date":"2030-05-07","underlying":"Common Shares","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000899243-20-012776","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600359/000089924320012776/doc4.xml","form_type":"4"}},{"id":3535157,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-08T16:23:57.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on date of next annual general meeting following grant date of May 6, 2019."}],"balance_after":10000,"derivative":{"exercise_price":19.11,"expiration_date":"2029-05-05","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-19-012638","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600359/000089924319012638/doc4.xml","form_type":"4"}},{"id":3880514,"issuer":{"id":158957,"kind":"organization","name":"Achaogen, Inc.","symbol":"AKAO"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-29T20:33:20.000Z","date":"2018-06-28","kind":"exercise","acquired":false,"shares":45208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of February 19, 2016, subject to the reporting person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":32292,"derivative":{"exercise_price":3.65,"expiration_date":"2026-02-26","underlying":"Common Stock","underlying_shares":45208},"source":{"system":"sec-edgar","filing":"0001140361-18-030785","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1600359/000114036118030785/doc1.xml","form_type":"4"}},{"id":3880513,"issuer":{"id":158957,"kind":"organization","name":"Achaogen, Inc.","symbol":"AKAO"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-29T20:33:20.000Z","date":"2018-06-28","kind":"exercise","acquired":false,"shares":132727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":6.93,"expiration_date":"2021-06-07","underlying":"Common Stock","underlying_shares":132727},"source":{"system":"sec-edgar","filing":"0001140361-18-030785","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1600359/000114036118030785/doc1.xml","form_type":"4"}},{"id":3880512,"issuer":{"id":158957,"kind":"organization","name":"Achaogen, Inc.","symbol":"AKAO"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-06-29T20:33:20.000Z","date":"2018-06-28","kind":"exercise","acquired":true,"shares":45208,"price":3.65,"value":165009.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 78,600 Restricted Stock Units."}],"balance_after":293336,"source":{"system":"sec-edgar","filing":"0001140361-18-030785","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600359/000114036118030785/doc1.xml","form_type":"4"}},{"id":3880511,"issuer":{"id":158957,"kind":"organization","name":"Achaogen, Inc.","symbol":"AKAO"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-06-29T20:33:20.000Z","date":"2018-06-28","kind":"exercise","acquired":true,"shares":132727,"price":6.93,"value":919798.11,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 78,600 Restricted Stock Units."}],"balance_after":248128,"source":{"system":"sec-edgar","filing":"0001140361-18-030785","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600359/000114036118030785/doc1.xml","form_type":"4"}},{"id":3881418,"issuer":{"id":158957,"kind":"organization","name":"Achaogen, Inc.","symbol":"AKAO"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-28T16:19:18.000Z","date":"2018-06-26","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 8, 2018, the issuer granted the reporting person Restricted Stock Units (\"RSUs\") and a stock option that each vest upon the achievement of certain milestones. On June 26, 2018, one of the milestones was achieved, resulting in vesting of a portion of the RSUs and shares subject to the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":10000,"derivative":{"exercise_price":10.64,"expiration_date":"2028-02-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-18-030423","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1600359/000114036118030423/doc1.xml","form_type":"4"}},{"id":3881417,"issuer":{"id":158957,"kind":"organization","name":"Achaogen, Inc.","symbol":"AKAO"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-06-28T16:19:18.000Z","date":"2018-06-26","kind":"sale","acquired":false,"shares":744,"price":9.59,"value":7134.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of RSUs of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 1,744 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2018 and (ii) 78,600 RSUs."}],"balance_after":115401,"source":{"system":"sec-edgar","filing":"0001140361-18-030423","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600359/000114036118030423/doc1.xml","form_type":"4"}},{"id":3881416,"issuer":{"id":158957,"kind":"organization","name":"Achaogen, Inc.","symbol":"AKAO"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-06-28T16:19:18.000Z","date":"2018-06-26","kind":"grant","acquired":true,"shares":2150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 8, 2018, the issuer granted the reporting person Restricted Stock Units (\"RSUs\") and a stock option that each vest upon the achievement of certain milestones. On June 26, 2018, one of the milestones was achieved, resulting in vesting of a portion of the RSUs and shares subject to the option."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 1,744 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2018 and (ii) 78,600 RSUs."}],"balance_after":116145,"source":{"system":"sec-edgar","filing":"0001140361-18-030423","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600359/000114036118030423/doc1.xml","form_type":"4"}},{"id":3932870,"issuer":{"id":158957,"kind":"organization","name":"Achaogen, Inc.","symbol":"AKAO"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-15T18:29:59.000Z","date":"2018-02-08","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of February 8, 2018, subject to the reporting person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":80000,"derivative":{"exercise_price":10.64,"expiration_date":"2028-02-08","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001140361-18-024051","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600359/000114036118024051/doc1.xml","form_type":"4"}},{"id":3932869,"issuer":{"id":158957,"kind":"organization","name":"Achaogen, Inc.","symbol":"AKAO"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-05-15T18:29:59.000Z","date":"2018-02-08","kind":"grant","acquired":true,"shares":17100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (\"RSUs\"). The reporting person is entitled to one (1) share of Common Stock for each one (1) RSU upon the vesting thereof."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 78,600 RSUs."}],"balance_after":112251,"source":{"system":"sec-edgar","filing":"0001140361-18-024051","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600359/000114036118024051/doc1.xml","form_type":"4"}},{"id":3994673,"issuer":{"id":158957,"kind":"organization","name":"Achaogen, Inc.","symbol":"AKAO"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-03-15T19:17:21.000Z","date":"2018-03-13","kind":"sale","acquired":false,"shares":2735,"price":11.74,"value":32108.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 61,500 RSUs."}],"balance_after":95151,"source":{"system":"sec-edgar","filing":"0001140361-18-013721","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600359/000114036118013721/doc1.xml","form_type":"4"}},{"id":4037070,"issuer":{"id":158957,"kind":"organization","name":"Achaogen, Inc.","symbol":"AKAO"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-23T20:37:04.000Z","date":"2018-02-21","kind":"sale","acquired":false,"shares":4606,"price":10.67,"value":49146.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 4,070 shares acquired under the issuer's Employee Stock Purchase Plan on May 31, 2017 and November 30, 2017 and (ii) 69,550 RSUs."}],"balance_after":97886,"source":{"system":"sec-edgar","filing":"0001140361-18-009969","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600359/000114036118009969/doc1.xml","form_type":"4"}},{"id":4382420,"issuer":{"id":158957,"kind":"organization","name":"Achaogen, Inc.","symbol":"AKAO"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-03-16T19:45:13.000Z","date":"2017-03-14","kind":"sale","acquired":false,"shares":3079,"price":26.58,"value":81839.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 81,675 RSUs."}],"balance_after":98422,"source":{"system":"sec-edgar","filing":"0001140361-17-012435","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600359/000114036117012435/doc1.xml","form_type":"4"}},{"id":4424711,"issuer":{"id":158957,"kind":"organization","name":"Achaogen, Inc.","symbol":"AKAO"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-24T20:21:49.000Z","date":"2017-02-22","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option shall vest on the following schedule: (i) 40% of the shares subject to the option will vest on the 30th consecutive date that the closing trading price of the Issuer's common stock first reaches or exceeds $30.00 per share; (ii) 40% of the shares subject to the option will vest on the 30th consecutive date that the closing trading price of the Issuer's common stock first reaches or exceeds $40.00 per share; and (iii) 20% of the shares subject to the option will vest on the 30th consecutive date that the closing trading price of the Issuer's common stock first reaches or exceeds $55.00 per share, subject to the reporting person's continued employment or service relationship with the Issuer on each such vesting date and as appropriately adjusted for stock splits, stock dividends, recapitalizations and the like."}],"balance_after":40000,"derivative":{"exercise_price":23.62,"expiration_date":"2026-02-22","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001140361-17-009249","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1600359/000114036117009249/doc1.xml","form_type":"4"}},{"id":4424710,"issuer":{"id":158957,"kind":"organization","name":"Achaogen, Inc.","symbol":"AKAO"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-24T20:21:49.000Z","date":"2017-02-22","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of February 22, 2017, subject to the reporting person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":160000,"derivative":{"exercise_price":23.62,"expiration_date":"2026-02-22","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001140361-17-009249","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600359/000114036117009249/doc1.xml","form_type":"4"}},{"id":4424709,"issuer":{"id":158957,"kind":"organization","name":"Achaogen, Inc.","symbol":"AKAO"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-02-24T20:21:49.000Z","date":"2017-02-22","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (\"RSUs\"). The reporting person is entitled to one (1) share of Common Stock for each one (1) RSU upon the vesting thereof."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 89,725 RSUs."}],"balance_after":101501,"source":{"system":"sec-edgar","filing":"0001140361-17-009249","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600359/000114036117009249/doc1.xml","form_type":"4"}},{"id":4427793,"issuer":{"id":158957,"kind":"organization","name":"Achaogen, Inc.","symbol":"AKAO"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-02-23T19:39:06.000Z","date":"2017-02-21","kind":"sale","acquired":false,"shares":1696,"price":22.76,"value":38600.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 49,725 Restricted Stock Units."}],"balance_after":61501,"source":{"system":"sec-edgar","filing":"0001140361-17-008924","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600359/000114036117008924/doc1.xml","form_type":"4"}},{"id":4477256,"issuer":{"id":158957,"kind":"organization","name":"Achaogen, Inc.","symbol":"AKAO"},"owners":[{"id":78480,"kind":"person","name":"Hillan Kenneth J.","position":1,"cik":"0001600359","reported_name":"Hillan Kenneth J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-01-30T21:35:50.000Z","date":"2017-01-26","kind":"sale","acquired":false,"shares":1431,"price":16.78,"value":24012.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 53,850 Restricted Stock Units and 3,000 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2016."}],"balance_after":63197,"source":{"system":"sec-edgar","filing":"0001140361-17-003547","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600359/000114036117003547/doc1.xml","form_type":"4"}}]}